BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9865517)

  • 1. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters.
    Kokoshka JM; Vaughan RA; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 1998 Nov; 361(2-3):269-75. PubMed ID: 9865517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.
    Sandoval V; Riddle EL; Ugarte YV; Hanson GR; Fleckenstein AE
    J Neurosci; 2001 Feb; 21(4):1413-9. PubMed ID: 11160413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid and reversible change in dopamine transporters induced by methamphetamine.
    Fleckenstein AE; Metzger RR; Gibb JW; Hanson GR
    Eur J Pharmacol; 1997 Apr; 323(2-3):R9-10. PubMed ID: 9128855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.
    Johnson RA; Eshleman AJ; Meyers T; Neve KA; Janowsky A
    Synapse; 1998 Sep; 30(1):97-106. PubMed ID: 9704886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and reversible effects of methamphetamine on dopamine transporters.
    Fleckenstein AE; Metzger RR; Wilkins DG; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1997 Aug; 282(2):834-8. PubMed ID: 9262348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76.
    Kimmel HL; Carroll FI; Kuhar MJ
    Neuropharmacology; 2000 Feb; 39(4):578-85. PubMed ID: 10728879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine decreases mouse striatal dopamine transporter activity: roles of hyperthermia and dopamine.
    Sandoval V; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2000 Dec; 409(3):265-71. PubMed ID: 11108820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine-induced decrease in tryptophan hydroxylase activity: role of 5-hydroxytryptaminergic transporters.
    Fleckenstein AE; Beyeler ML; Jackson JC; Wilkins DG; Gibb JW; Hanson GR
    Eur J Pharmacol; 1997 Apr; 324(2-3):179-86. PubMed ID: 9145769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal by [D-Ala2,D-Leu5]enkephalin of the dopamine transporter loss caused by methamphetamine.
    Tsao LI; Cadet JL; Su TP
    Eur J Pharmacol; 1999 May; 372(3):R5-7. PubMed ID: 10395030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.
    Xu C; Coffey LL; Reith ME
    Biochem Pharmacol; 1995 Jan; 49(3):339-50. PubMed ID: 7857321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats.
    Masserano JM; Venable D; Wyatt RJ
    J Pharmacol Exp Ther; 1994 Jul; 270(1):133-41. PubMed ID: 8035309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced responsiveness to novelty and cocaine is associated with decreased basal dopamine uptake and release in the nucleus accumbens: quantitative microdialysis in rats under transient conditions.
    Chefer VI; Zakharova I; Shippenberg TS
    J Neurosci; 2003 Apr; 23(7):3076-84. PubMed ID: 12684494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain.
    Kokoshka JM; Metzger RR; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    Brain Res; 1998 Jul; 799(1):78-83. PubMed ID: 9666084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
    Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
    J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function.
    Metzger RR; Hanson GR; Gibb JW; Fleckenstein AE
    Eur J Pharmacol; 1998 May; 349(2-3):205-10. PubMed ID: 9671099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations.
    Villemagne V; Yuan J; Wong DF; Dannals RF; Hatzidimitriou G; Mathews WB; Ravert HT; Musachio J; McCann UD; Ricaurte GA
    J Neurosci; 1998 Jan; 18(1):419-27. PubMed ID: 9412518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotransmitter transporters synthesis and degradation rates.
    Kimmel H; Vicentic A; Kuhar MJ
    Life Sci; 2001 Apr; 68(19-20):2181-5. PubMed ID: 11358326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grafts modulate dopamine transporters of the non-lesioned striatum.
    Schäfer U; Reum T; Schönfuss D; Marburger A; Morgenstern R
    Neuroreport; 1995 Oct; 6(14):1833-6. PubMed ID: 8547578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo effects of cocaine and selected local anesthetics on the dopamine transporter.
    Woodward JJ; Compton DM; Balster RL; Martin BR
    Eur J Pharmacol; 1995 Apr; 277(1):7-13. PubMed ID: 7635175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
    Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.